 |
|
Role of Blood Lipid Levels and Lipid-Lowering Therapy in Stroke Patients with Different Levels of Cerebral Artery Diseases: Reconsidering Recent Stroke Guidelines
Jong S. Kim
J Stroke. 2021;23(2):149-161. Published online 2021 May 31 DOI: https://doi.org/10.5853/jos.2021.01249
|
|
Citations to this article as recorded by
 Medical Management of Dyslipidemia for Secondary Stroke Prevention: Narrative Review
Yoonkyung Chang, Soojeong Eom, Minjeong Kim, Tae-Jin Song
Medicina.2023; 59(4): 776. CrossRef Statin treatment and cerebral microbleeds: A risk assessment
Tomoyuki Kawada
Journal of the Neurological Sciences.2022; 432: 120038. CrossRef Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer
Yoichi Morofuji, Shinsuke Nakagawa, Kenta Ujifuku, Takashi Fujimoto, Kaishi Otsuka, Masami Niwa, Keisuke Tsutsumi
Pharmaceuticals.2022; 15(2): 151. CrossRef Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention
Meng Lee, Chun-Yu Cheng, Yi-Ling Wu, Jiann-Der Lee, Chia-Yu Hsu, Bruce Ovbiagele
JAMA Neurology.2022; 79(4): 349. CrossRef The Underlying Role of the Glymphatic System and Meningeal Lymphatic Vessels in Cerebral Small Vessel Disease
Yu Tian, Mengxi Zhao, Yiyi Chen, Mo Yang, Yilong Wang
Biomolecules.2022; 12(6): 748. CrossRef Excessive Visit-to-Visit Small and Dense Low-Density Lipoproteins Elevate Cerebral Small Vessel Disease Progression Risk in the Elderly
Weike Liu, Jing Xu, Huajing Song, Chunju Zhang, Yanli Yao, Hua Zhang, Yue-Chun Li, Zhendong Liu
Frontiers in Neurology.2022;[Epub] CrossRef
|